Dental implant surgery for patients on oral anticoagulants

ISRCTN ISRCTN36419844
DOI https://doi.org/10.1186/ISRCTN36419844
Secondary identifying numbers 006
Submission date
02/03/2009
Registration date
17/03/2009
Last edited
17/03/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Hamad Al Zoman
Scientific

Sultan Bin Abdulaziz Humanitarian City
P.O. Box 64399
Riyadh
11536
Saudi Arabia

Study information

Study designObservational cohort case study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleFlapless dental implant surgery for patients on oral anticoagulants: a novel bridging paradigm between clinical technique and therapeutic guidelines (WarLess Procedure)
Study objectivesTo evaluate the combination of minimally invasive flapless dental implant surgery without interrupting the regular dose of the anticoagulant medications.
Ethics approval(s)Research and Ethics Committee, Sultan Bin Abdulaziz Humanitarian City gave approval on the 23rd March 2007 (ref: 006)
Health condition(s) or problem(s) studiedHaematology/dental implants
InterventionMales and females with a history of rheumatic heart disease were included for the case study. Four tablets of amoxicillin 500 mg (2 grams) were given to both patients one hour pre-operatively as a prophylactic antibiotic. Patients were instructed to rinse their mouth for 30 seconds with mouth rinse (chlorhexidine) prior to the dental surgery. Infiltration of one carpule of local anaesthesia (2% lidocaine with 1:100,000 epinephrine) was administered around the edentulous area and then the flapless dental implant procedure was peformed. Radiographic images were taken pre- and post-implant insertion. Patients were given post-operative instructions and the antibiotic was prescribed (amoxicillin 500 mg, three times/day) for the next ten days with analgesics (ibuprofen 400 mg) to be taken only in need.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Amoxicillin, chlorhexidine, lidocaine, epinephrine, ibuprofen
Primary outcome measure1. Bone healing
2. No bleeding

Measured at baseline, 1-week, 4-week and 6-month follow-up visit.
Secondary outcome measuresNo secondary outcome measures
Overall study start date06/04/2007
Completion date29/09/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants2
Key inclusion criteria1. History of rheumatic heart disease
2. Long term anticoagulant maintenance therapy with warfarin
3. Missing tooth/teeth
4. Both sexes, aged from 40 to 60 years
Key exclusion criteria1. International normalised ratio (INR) greater than 4.1
2. No missing tooth/teeth
Date of first enrolment06/04/2007
Date of final enrolment29/09/2008

Locations

Countries of recruitment

  • Saudi Arabia

Study participating centre

Sultan Bin Abdulaziz Humanitarian City
Riyadh
11536
Saudi Arabia

Sponsor information

King Abdulaziz City for Science and Technology (Saudi Arabia)
Government

General Directorate of Research Grants Programmes
P.O Box 6086
Riyadh
11442
Saudi Arabia

Website http://www.kacst.edu.sa
ROR logo "ROR" https://ror.org/05tdz6m39

Funders

Funder type

Research organisation

King Abdulaziz City for Science and Technology (Saudi Arabia) - General Directorate of Research Grants Programmes

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan